Full-Time

Lead Dosing Session Monitor

Updated on 9/3/2026

Adams Clinical

Adams Clinical

201-500 employees

Performs late-phase, double-blind psychiatric trials

Compensation Overview

$60 - $70/hr

+ 401(k) / 401(k) matching

Boston, MA, USA + 4 more

More locations: Dallas, TX, USA | Bronx, NY, USA | Edgewater, NJ, USA | Belmont, MA, USA

Hybrid

Majority on-site; 2-3 days per week remote possible.

PhD

Category
Medical, Clinical & Veterinary (1)

Get referred to Adams Clinical

See people who can refer or advise you

Requirements
  • Licensed mental health professional in Massachusetts, New York, Pennsylvania, or Texas (e.g., PsyD, PhD, LCSW, LMSW, LMHC, LMFT), with the ability to provide psychotherapy in compliance with state regulations
  • Attention to detail is critical for this role to ensure accurate observation, documentation, and reporting of dosing sessions, with strict adherence to ICH-Good Clinical Practice standards and protocol requirements
  • Experience working with individuals with depression, anxiety, or other mood disorders
  • Strong interpersonal and communication skills, with an interest in advancing mental health care in a clinical research setting
  • Ability to meet fixed scheduling expectations, including consistent on-site availability
  • Final candidate must be approved by both Adams Clinical and the study sponsor
Responsibilities
  • Lead Study Therapist in psychedelic clinical trials for depression, anxiety, and other mood disorders
  • Complete study-sponsored therapist training, and Adams Clinical site-specific training requirements
  • Provide support to participants throughout the clinical trial in alignment with the study protocol and training guidelines
  • Collaborate with clinicians and site staff managing participant participation in the study
Desired Qualifications
  • Willingness to travel between regional sites is a plus, but not required

Adams Clinical conducts late-phase psychiatric and neurologic clinical trials under FDA rules, using double-blind, randomized, placebo-controlled designs for investigational drugs that have advanced past initial testing. Nine full-time doctors serve as neutral third parties to oversee trials and ensure unbiased results; data integrity comes from careful participant selection and rigorous rater training. The company provides external testing required by law (Chapter 21 CFR Part 54) for pharmaceutical companies seeking evidence of efficacy and safety, generating revenue from sponsors. With high academic standards and small, focused trial numbers in depression research, Adams Clinical aims to deliver reliable data to support regulatory decisions on new psychiatric and neurologic drugs.

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

Watertown, Massachusetts

Founded

2011

Get referred to Adams Clinical

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • InTandem Capital invested on 2024-05-21, bringing growth capital and healthcare-services expertise.
  • The 2024-08-20 Bronx lease at Hutchinson Metro Center expands capacity in a dense patient market.
  • Adams had 30-plus active openings in 2026-08-29, signaling commercial demand and network expansion.

What critics are saying

  • Psychiatric trial recruitment failures can sink timelines, and Adams runs 38 open jobs in 2026.
  • FDA audit findings or data-integrity lapses would jeopardize sponsor trust and future protocols.
  • InTandem-backed growth pressures execution; one failed inpatient rollout could damage the whole network.

What makes Adams Clinical unique

  • Adams Clinical spans six sites across four states as of 2026-07-28.
  • Its 2024-12-11 InSite partnership adds inpatient schizophrenia and psychiatry trial capabilities.
  • Adams emphasizes doctorate-level raters and physician oversight, reinforcing sponsor trust and data quality.

Help us improve and share your feedback! Did you find this helpful?

Benefits

401(k) Company Match

Health Insurance

Dental Insurance

Vision Insurance

Health Savings Account/Flexible Spending Account

Paid Vacation

Parental Leave

Professional Development Budget

Life Insurance

Growth & Insights and Company News

Headcount

6 month growth

24%

1 year growth

24%

2 year growth

24%
BioSpace
Dec 11th, 2024
Adams Clinical Announces Expansion into Inpatient Psychiatry and Schizophrenia Clinical Trial Capabilities with Signing of Partnership with InSite Clinical Research

Adams Clinical announces expansion into inpatient Psychiatry and Schizophrenia clinical trial capabilities with signing of partnership with InSite Clinical Research.

BXTimes
Aug 22nd, 2024
Lease signed for new medical center at Hutchinson Metro Center

The real estate investment firm Simone Development Companies has inked a long-term lease agreement with medical research institute Adams Clinical, Inc. for the opening of a Davis Clinical medical research center at the Hutchinson Metro Center in the Bronx.

Business Wire
May 21st, 2024
InTandem Capital Partners Announces Investment in Adams Clinical

InTandem Capital Partners announces investment in Adams Clinical.